PPT-Multi Drug Resistant Tuberculosis (MDR-TB) Among HIV-Positive Patients in A Tertiary
Author : olivia-moreira | Published Date : 2018-12-12
Akujobi CN Okoro CE Anyabolu AE Okonkwo RC Onwunzo MC and Chukwuka CP Tuberculosis TB is the most common opportunistic infection in Human Immuno d eficiency
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Multi Drug Resistant Tuberculosis (MDR-T..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Multi Drug Resistant Tuberculosis (MDR-TB) Among HIV-Positive Patients in A Tertiary: Transcript
Akujobi CN Okoro CE Anyabolu AE Okonkwo RC Onwunzo MC and Chukwuka CP Tuberculosis TB is the most common opportunistic infection in Human Immuno d eficiency Virus HIV. co-infected with extensively drug-resistant tuberculosis (XDR-TB) and HIV, but treatment outχomes have not been reported. We report treatment outχomes for adult XDR TB patients in Kwa June 2012. Overview. Operation ASHA . is a non-profit bringing tuberculosis treatment to more than 5 million of India and Cambodia’s poorest.. eCompliance. . is a biometric terminal . that contributes to preventing drug-resistant strains of tuberculosis from developing during patient treatment.. of Tuberculosis Internationally. Tuberculosis Control In Vulnerable Groups. Bulletin of the World Health Organization. TB is an in important public health problem in industrialized countries. Most cases occur in minority groups. of Tuberculosis Internationally. Tuberculosis Control In Vulnerable Groups. Bulletin of the World Health Organization. TB is an in important public health problem in industrialized countries. Most cases occur in minority groups. Bruce A. Bush, M.D.. Regional Tuberculosis Consultant. Pennsylvania Department of Health. Senior Vice President for Medical Affairs. Indiana Regional Medical Center. Disclosures. I do not have any financial arrangements or affiliations with a commercial entity.. Location here]. Ethics of Tuberculosis Prevention, Care and Control. MODULE 11: conclusion. Insert country/ministry logo here. Objectives. Upon completion of this . module, you . will be able to. :. Discuss emerging ethical issues in TB prevention care and control. ries 14 61 contributed data on 17690 isolates whichThese drugs are more costly toxic and less effective thanfirst-line drugs used for routine treatment of TB with other diseases resistance to TB drugs TB has existed since antiquity . T. he oldest unambiguously detected mycobacterium tuberculosis give evidence of the disease in the remains of bison in Wyoming dated around 17.000 years ago . TB in human can be traced back ti 9.000 years ago in Haifa archeologists found TB in remains of mother and child buried together. Dr.. . Mohit. Bhatia. Assistant Professor. Department of Microbiology. AIIMS, . Rishikesh. LAYOUT. Introduction to Mycobacteria. Laboratory Diagnosis. General Features of Mycobacteria. Acid fastness . [NAME OF PRESENTER]. [TITLE OF PRESENTER]. STREAM Clinical Trial. Overview of the presentation. Outline. Burden of disease. TB treatments. Conclusions. Status of MDR TB in the world. Status of MDR/RR-TB . meningitis in the United States, 1993-2005. Presenter: . Christopher Vinnard. World Epidemiology Congress 2011. Edinburgh, Scotland. Disclosures. No authors have financial or non-financial conflicts of interests that may be relevant to this presentation. Ntombasekhaya. . Mlandu. , PN, CNP, BScN, MPH. Primary Care Nurse Practitioner. Eastern Cape, South Africa. Prof. Jason E. Farley, PhD, MPH, ANP-BC. Professor & Nurse Practitioner. Johns Hopkins University School of Nursing & Medicine . 91 and extensively drug resistant TB 92 and extensively drug resistant TBficient anti TB programs were the most affected by multi-resistance. Global resistance figures prov Shah N, Richardson J, Moodley P, Moodley S, Babaria P, Ramtahal M, et al. Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa. Emerg Infect Dis. 2011;17(3):510-513. https://doi.org/10.3201/eid1703.101363.
Download Document
Here is the link to download the presentation.
"Multi Drug Resistant Tuberculosis (MDR-TB) Among HIV-Positive Patients in A Tertiary"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents